Jens Bukh

Jens Bukh

Professor

Member of:


    1. Published

      Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failure

      STOP-HCV Consortium, S. C., 2021, In: Nature Communications. 12, 1, 11 p., 6105.

      Research output: Contribution to journalJournal articleResearchpeer-review

    2. Published

      Vaccines against hepatitis C: A travel into neutralisation space

      Bukh, Jens, 2021, In: Gut. 70, 9, p. 1609-1610 2 p., 323377.

      Research output: Contribution to journalComment/debateResearchpeer-review

    3. Published

      Sars-cov-2 production in a scalable high cell density bioreactor

      Offersgaard, Anna Falden, Hernandez, C. R. D., Pihl, A. F., Costa, Rui, Venkatesan, N. P., Lin, X., Pham, Long, Feng, S., Fahnøe, Ulrik, Scheel, Troels Kasper Høyer, Ramirez Almeida, Santseharay, Reichl, U., Bukh, Jens, Genzel, Y. & Gottwein, Judith Margarete, 2021, In: Vaccines. 9, 7, 706.

      Research output: Contribution to journalJournal articleResearchpeer-review

    4. Published

      Pathogenesis, miR-122 gene-regulation, and protective immune responses after acute equine hepacivirus infection

      Tomlinson, J. E., Wolfisberg, R., Fahnøe, Ulrik, Patel, R. S., Trivedi, S., Kumar, A., Sharma, H., Nielsen, L., McDonough, S. P., Bukh, Jens, Tennant, B. C., Kapoor, A., Rosenberg, B. R., Rice, C. M., Divers, T. J., Van de Walle, G. R. & Scheel, Troels Kasper Høyer, 2021, In: Hepatology. 74, 3, p. 1148-1163

      Research output: Contribution to journalJournal articleResearchpeer-review

    5. Published

      Overcoming culture restriction for SARS-CoV-2 in human cells facilitates the screening of compounds inhibiting viral replication

      Ramirez Almeida, Santseharay, Fernandez-Antunez, C., Galli, Andrea, Underwood, Alexander Paul James, Pham, Long, Ryberg, Line Abildgaard, Feng, S., Pedersen, M. S., Mikkelsen, L. S., Belouzard, S., Dubuisson, J., Sølund, C., Weis, Nina, Gottwein, Judith Margarete, Fahnøe, Ulrik & Bukh, Jens, 2021, In: Antimicrobial Agents and Chemotherapy. 65, 7, 20 p., e00097-21.

      Research output: Contribution to journalJournal articleResearchpeer-review

    6. Published

      Neutralisation titres against SARS-CoV-2 are sustained 6 months after onset of symptoms in individuals with mild COVID-19

      Underwood, Alexander Paul James, Sølund, C., Fernandez-Antunez, C., Villadsen, S. L., Winckelmann, A. A., Bollerup, S., Mikkelsen, L. S., Sørensen, A. L., Feng, S., Fahnøe, Ulrik, Lassauniere, R., Fomsgaard, A., Ramirez Almeida, Santseharay, Weis, Nina & Bukh, Jens, 2021, In: EBioMedicine. 71, 103519.

      Research output: Contribution to journalJournal articleResearchpeer-review

    7. Published
    8. Published

      Inferior cure rate in pilot study of 4-week glecaprevir/pibrentasvir treatment with or without ribavirin of chronic hepatitis C

      Madsen, L. W., Christensen, P. B., Fahnøe, Ulrik, Pedersen, M. S., Bukh, Jens & Øvrehus, A., 2021, In: Liver International. 41, 11, p. 2601-2610

      Research output: Contribution to journalJournal articleResearchpeer-review

    9. Published

      In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

      Zhou, Y., Gilmore, K., Ramirez Almeida, Santseharay, Settels, E., Gammeltoft, Karen Anbro, Pham, Long, Fahnøe, Ulrik, Feng, S., Offersgaard, Anna Falden, Trimpert, J., Bukh, Jens, Osterrieder, K., Gottwein, Judith Margarete & Seeberger, P. H., 2021, In: Scientific Reports. 11, 14571.

      Research output: Contribution to journalJournal articleResearchpeer-review

    10. Published

      Hepatitis C virus envelope protein dynamics and the link to hypervariable region 1

      Augestad, Elias Honerød, Bukh, Jens & Prentø, Jannick, 2021, In: Current Opinion in Virology. 50, p. 69-75 7 p.

      Research output: Contribution to journalReviewResearchpeer-review

    Previous 1 2 Next

    ID: 12437